Qasim Rizvi

Qasim Rizvi

Qasim Rizvi is a trained surgeon and highly accomplished health care executive with broad experience in the biopharmaceuticals industry. He has a distinguished track record of innovation and operational excellence, coupled with a strong commitment to collaboration and...
Chris Heberlig

Chris Heberlig

Chris Heberlig has more than two decades of financial, strategic and operational experience in the biotechnology industry with a background supporting companies advancing from private to public markets and from early-stage development towards commercialization. Prior...
Lance Ostrom

Lance Ostrom

Lance brings over 20 years industry experience and over the past ten years has focused his work in business development at large pharmaceutical companies and small biotechs.  At KSQ he’s led three major transactions with Ono, Takeda and Roche resulting in significant...
Micah Benson

Micah Benson

Micah Benson joined KSQ at its founding and was responsible for building KSQ’s Immuno-Oncology and Autoimmunity efforts, leading to a clinical-stage portfolio of multiple first-in-class therapeutics. A co-inventor of KSQ’s foundational Immune CRISPRomics® platform,...
Thomas Leitch

Thomas Leitch

Tom brings nearly 25 years of leadership experience in cell & gene therapy, biologics, and vaccines to his role as Chief Technology Officer. His experiences span Manufacturing Sciences, CMC Strategy Development, Internal and External Manufacturing Operations,...